Literature DB >> 16024757

Mechanisms of progesterone-induced neuroprotection.

Meharvan Singh1.   

Abstract

Gonadal steroid hormones such as estrogen and progesterone can no longer be considered strictly within the confines of reproductive function, and with respect to their anatomic targets, extrahypothalamic structures within the brain such as the cerebral cortex have revealed themselves to be important targets. As such, it may come as no surprise that the decline in such hormones, which occurs after the menopause or ovariectomy, can result in neuronal dysfunction. Although estrogen has been shown to help restore the deficits consequent to ovariectomy, it is important to consider that ovariectomy, like the menopause, results in the precipitous loss of not only estrogen but of progesterone as well. As such, the loss of progesterone may contribute to the deficits observed after ovariectomy or the increased risk for Alzheimer's disease seen after the menopause. Indeed, recent evidence supports the neuroprotective potential of progesterone itself. Here, we review the current understanding of some of the diverse mechanisms by which progesterone may reduce neuronal vulnerability to toxic insults relevant to age and age-associated diseases such as Alzheimer's disease. Further, we comment on the need to carefully consider the various preparations of progestins that are currently available and argue that "not all progestins are created equal," at least when it comes to influences on neuroprotection and other extrahypothalamic brain functions.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16024757     DOI: 10.1196/annals.1347.010

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  10 in total

1.  Progesterone increases the release of brain-derived neurotrophic factor from glia via progesterone receptor membrane component 1 (Pgrmc1)-dependent ERK5 signaling.

Authors:  Chang Su; Rebecca L Cunningham; Nataliya Rybalchenko; Meharvan Singh
Journal:  Endocrinology       Date:  2012-07-09       Impact factor: 4.736

Review 2.  Multiple pathways transmit neuroprotective effects of gonadal steroids.

Authors:  Damani N Bryant; Laird C Sheldahl; Lisa K Marriott; Robert A Shapiro; Daniel M Dorsa
Journal:  Endocrine       Date:  2006-04       Impact factor: 3.633

3.  Reproductive factors, exogenous estrogen use, and risk of Parkinson's disease.

Authors:  Kelly Claire Simon; Honglei Chen; Xiang Gao; Michael A Schwarzschild; Alberto Ascherio
Journal:  Mov Disord       Date:  2009-07-15       Impact factor: 10.338

4.  Formulations of hormone therapy and risk of Parkinson's disease.

Authors:  Jessica I Lundin; Thanh G N Ton; Andrea Z LaCroix; W T Longstreth; Gary M Franklin; Phillip D Swanson; Terri Smith-Weller; Brad A Racette; Harvey Checkoway
Journal:  Mov Disord       Date:  2014-09-25       Impact factor: 10.338

5.  Female reproductive factors, menopausal hormone use, and Parkinson's disease.

Authors:  Rui Liu; Donna Baird; Yikyung Park; Neal D Freedman; Xuemei Huang; Albert Hollenbeck; Aaron Blair; Honglei Chen
Journal:  Mov Disord       Date:  2013-12-18       Impact factor: 10.338

6.  Progesterone, administered before kainic acid, prevents decrements in cognitive performance in the Morris Water Maze.

Authors:  Cheryl A Frye; Alicia Walf
Journal:  Dev Neurobiol       Date:  2011-02       Impact factor: 3.964

Review 7.  Neurosteroids' effects and mechanisms for social, cognitive, emotional, and physical functions.

Authors:  Cheryl A Frye
Journal:  Psychoneuroendocrinology       Date:  2009-12       Impact factor: 4.905

8.  Dorsal hippocampal progesterone infusions enhance object recognition in young female mice.

Authors:  Patrick T Orr; Michael C Lewis; Karyn M Frick
Journal:  Pharmacol Biochem Behav       Date:  2009-05-27       Impact factor: 3.533

9.  Progesterone stimulates the proliferation of female and male cholangiocytes via autocrine/paracrine mechanisms.

Authors:  Shannon Glaser; Sharon DeMorrow; Heather Francis; Yoshiyuki Ueno; Eugenio Gaudio; Shelley Vaculin; Julie Venter; Antonio Franchitto; Paolo Onori; Bradley Vaculin; Marco Marzioni; Candace Wise; Metaneeya Pilanthananond; Jennifer Savage; Lisa Pierce; Romina Mancinelli; Gianfranco Alpini
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2008-05-29       Impact factor: 4.052

10.  Progesterone Treatment Shows Benefit in Female Rats in a Pediatric Model of Controlled Cortical Impact Injury.

Authors:  Rastafa I Geddes; Bethany L Peterson; Donald G Stein; Iqbal Sayeed
Journal:  PLoS One       Date:  2016-01-22       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.